$GNBT News Article - Generex Biotechnology Announces First Patient Enrolled in the Phase II Clinical Trial of AE37 in Combination with Pembrolizumab (Keytruda ) for the Treatment of Triple Negative Breast Cancer
https://marketwirenews.com/news-releases/gene...76013.html